BioCryst Pharmaceuticals Inc.

(BCRX) Trade

By |

Profile

Biocryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modelling, and medical chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Contact Information

Website: www.biocryst.com
Email: investorrelations@biocryst.com
Main Phone: +1 919 859-1302
Address: 4505 Emperor Boulevard
Address 2: Suite 200
State: NC
City / Town: Durham
Country: USA
Postal Code: 27703

Issuer Information

Exchange: NGS
CEO: Jon P. Stonehouse
Employees: 85
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 9.06 $ 0. (0.00%)
Last Price 9.06 Change $ 0. Change % 0.00 Tick N/A
Bid 8.60 Bid Size 500.00 Ask 9.60 Ask Size 100.00
Open N/A High N/A Low N/A Prev Close 9.06
Last Trade Volume 0 52 Wk Hi 9.71 52 Wk Low 4.25
Market Cap 993.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 109,641,044.00 EPS (TTM) -0.93 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 7 33
Number of Buys 5 16
Number of Sells 2 17
Net Activity 84394 36413
Last 10 Buys Shares
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Last 10 Sell Shares
William P. Sheridan 1,000
William P. Sheridan 1,000
Fred E. Cohen 1,000
Thomas R. Staab 1,000
Thomas R. Staab 1,000
Thomas R. Staab 1,000
Thomas R. Staab 1,000
Thomas R. Staab 1,000
Thomas R. Staab 1,000
Alane Barnes 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 4 4 4 4
Mean Target Price Estimate 6.6 6.6 6.6 6.6
Standard Deviation 2.19 2.19 2.19 2.19
Date of Most Recent Estimate 05/10/18 05/10/18 05/10/18 05/10/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 5
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 1.86 1.86 1.86 1.75